Compare LRMR & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LRMR | LFMD |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.1M | 330.5M |
| IPO Year | N/A | N/A |
| Metric | LRMR | LFMD |
|---|---|---|
| Price | $3.56 | $3.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $16.71 | $10.22 |
| AVG Volume (30 Days) | 1.6M | ★ 1.6M |
| Earning Date | 11-05-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $250,091,814.00 |
| Revenue This Year | N/A | $21.50 |
| Revenue Next Year | N/A | $17.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 28.78 |
| 52 Week Low | $1.61 | $3.43 |
| 52 Week High | $6.91 | $15.84 |
| Indicator | LRMR | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 24.14 |
| Support Level | $3.32 | $3.78 |
| Resistance Level | $3.79 | $4.06 |
| Average True Range (ATR) | 0.24 | 0.30 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 58.77 | 19.16 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.